Oncology News

Pfizer Inc said a late stage trial testing its cancer drug Sutent in advanced colon cancer was discontinued after it was deemed to be no more effective than standard chemotherapy.

A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended.

Main Category: Cancer / Oncology Also Included In: Pregnancy / Obstetrics Article Date: 02 Jul 2009 Survivors of childhood cancer run particular risks when pregnant and should be closely monitored, the 25th annual conference of the European Society of Human Reproduction and Embryology heard today .

The search is on for fifty cancer patients undergoing chemo or radiotherapy to trial an innovative, natural cosmetic product, Evonail, aimed at reversing the damage done to cracked or broken nails during anti-cancer treatments.

Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology .

A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended.

Myriad Pharmaceuticals, Inc. today announced that it has completed its previously announced spin-off from Myriad Genetics, Inc.

Published: Tuesday, June 30, 2009 at 5:11 a.m. Last Modified: Tuesday, June 30, 2009 at 5:11 a.m. For those who have never been seriously ill, treatment often seems cut and dried.

Main Category: Obesity / Weight Loss / Fitness Also Included In: Cancer / Oncology Smoking / Quit Smoking UA scientists looking at the link between BMI over a lifetime and the risk of developing pancreatic cancer found that overweight and obese young adults are more likely to develop the disease, and also that older adults with pancreatic cancer ...

A study published in the July 2009 issue of the Journal of Thoracic Oncology revealed that internet-based lung cancer information was of a higher quality in the United States than in Japan.

A thriving construction business, a precious 11 year old daughter and a happy long-term relationship.

Dr. O. Carl Simonton, a radiation oncologist who was an early advocate of treating the emotional and psychological needs of cancer patients and published the popular 1978 book "Getting Well Again," has died.

Higher selenium levels in the blood may worsen prostate cancer in some men who already have the disease, according to a study by researchers at Dana-Farber Cancer Institute the University of California, San Francisco.

The decision to use expensive cancer therapies that typically produce only a relatively short extension of survival is a serious ethical dilemma in the U.S. that needs to be addressed by the oncology community, according to a commentary published online June 29 in the Journal of the National Cancer Institute .

Jun 29, 2009 - Rexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has signed an exclusive collaboration and option for license agreement with a top 20 global pharmaceutical company for the development of RX-3117. RX-3117 is a small ...

A new analysis of the incidence of breast cancer in Italy per 100,000 women between the ages of 0 to 84 from 2000 to 2005 shows a 72 percent spike above official estimates issued by the Ministry of Health, with the sharpest uptick of +28.6 percent found in the youngest group studied .

An oncologist blamed for botching cancer treatments at the Philadelphia Veterans Affairs Medical Center says he's not the rogue physician he's been portrayed to be.Dr. Gary Kao is testifying at a congressional hearing at the medical center in Philadelphia.

Researchers have identified a genetic glitch that could lead to development of neuroblastoma, a deadly form of cancer that typically strikes children under 2. Two University of Florida scientists are part of the multicenter team of researchers that made the discovery, which could pave the way for better treatments that target the disease, according ...

Biovest International, Inc. , a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc.

AB Science, a young Paris-based biotech company, announces the pan-European commercial launch of its Masivet veterinary anticancer drug in June 2009.